ResMed RMD Ratios & Valuation
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 61.6%+0.7pp | 60.9%+0.8pp | 60.1%+0.7pp | 59.4%+0.6pp | 58.8%+0.4pp | |
| Operating margin | 34.2%+0.5pp | 33.7%+0.5pp | 33.2%+0.4pp | 32.7%+0.6pp | 32.1%+0.4pp | |
| Net margin | 27.4%-0.1pp | 27.5%+0.2pp | 27.4%+0.1pp | 27.2%+1.1pp | 26.2%+0.8pp | |
| Returns | ||||||
| Return on equity | 25.2%-0.4pp | 25.7%+0.3pp | 25.4%-0.4pp | 25.9%+0.1pp | 25.8%+0.2pp | |
| Return on invested capital | 26.5%+0.9pp | 25.6%+0.5pp | 25.1%-0.2pp | 25.3%+1.0pp | 24.3%+1.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | 0.7×0.0× | |
| Liquidity | ||||||
| Current ratio | 3×-0.1× | 3.1×+0.2× | 2.9×-0.6× | 3.4×0.0× | 3.4×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.1×0.0× | 0.2×0.0× | |
| Net debt / EBITDA | -0.3×-0.1× | -0.2×0.0× | -0.1×0.0× | -0.2×-0.1× | -0×-0.2× | |
| Per Share | ||||||
| Book value per share | $44.55+3.2% | $43.18+3.6% | $41.67+2.9% | $40.50+7.5% | $37.67+5.8% | |
| Valuation | ||||||
| Market capitalization | $32.7B-7.0% | $35.16B-12.3% | $40.08B+6.8% | $37.52B+14.1% | $32.88B-2.1% | |
| Price / earnings | 21.5×-2.1× | 23.7×-4.2× | 27.9×+1.1× | 26.8×+1.8× | 25×-1.9× | |
| Price / sales | 5.9×-0.6× | 6.5×-1.1× | 7.6×+0.3× | 7.3×+0.7× | 6.5×-0.3× | |
| Price / book | 5×-0.5× | 5.6×-1.0× | 6.5×+0.3× | 6.3×+0.4× | 5.9×-0.5× | |
| EV / EBITDA | 15.2×-2.0× | 17.2×-3.2× | 20.5×+0.7× | 19.7×+1.4× | 18.3×-1.2× | |
| Dividend yield | 1%+0.1pp | 0.9%+0.1pp | 0.8%0.0pp | 0.8%-0.1pp | 0.9%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ResMed's profit margins?
- ResMed (RMD) runs a 61.6% gross margin and a 34.2% operating margin, with a 27.4% net margin.
- Where do ResMed's ratios come from?
- Every ratio is computed from ResMed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
